Vilin Bio Med Limited
₹18.00
+0.00%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Low debt: debt-to-equity of 0.01.
- Comfortable interest cover: operating profit covers interest about 45.7 times.
- Return on capital employed is moderate at 10.8%.
- Profit has compounded about 74% a year over five years.
- Sales have compounded about 30% a year over five years.
- Promoters hold a majority stake (56.65%).
!Watch-points
- Return on equity is on the lower side at 7.5%.
- Net profit margin is slim at 4.6%.
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreSafe zone
3.58
In Altman’s original study, companies in this range showed a low incidence of financial distress.
Computed without the working-capital term (current-asset split not available for this stock).
Piotroski F-ScoreModerate
6 / 7
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 7 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap₹ 27 Cr
Current Price₹ 18.00
High / Low₹ 60.95 / 18.95
Stock P/E13.138686
Book Value₹ 18.60
Dividend Yield0%
ROCE10.80%
ROE7.51%
Face Value₹ 10.00
Debt to Equity0.01
PEG Ratio2.91
EV / EBITDA25.92
Industry PE35.70
P/B Ratio0.9114385
EPS₹ 1.27
Debt₹ 0 Cr
PAT Margin4.57%
Cash PAT₹ 2 Cr
ICR45.71
Promoter Holding56.65%
FII Holding—
DII Holding—
Public Holding43.35%
Note on calculated ratios: where a value is not published in the source data, we compute it from the reported financials — Debt to Equity = total borrowings ÷ (equity capital + reserves); EV / EBITDA = (market cap + debt − cash) ÷ (operating profit + depreciation); PEG = P/E ÷ 3-year profit growth %. These may differ slightly from other sources that use different periods or TTM figures. Current Price, Market Cap and P/E reflect the live quote (cached 15 min).
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity